Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Roche's T-type calcium channel blocker receives European approval

July 3, 1997

Novel antifibrillatory agent: DP-16

July 3, 1997

Pharmacological profile of BMS-186716 characterized

July 2, 1997

Antioxidant diester reported by Senju

July 2, 1997

Roche describes endothelin antagonists

July 2, 1997

ET antagonists claimed by Bristol-Myers Squibb

July 2, 1997

JTV-506: a potent and selective coronary vasodilator from Japan Tobacco

July 1, 1997

YM-435 shows promise in acute hypertensive episodes

July 1, 1997

PST-2238: a highly potent antihypertensive agent with a novel mechanism of action

June 30, 1997

FDA advisory committee recommends Corlopam approval

June 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...